Literature DB >> 8696536

The atherogenic potential of endothelin.

D Hasdai1, A Lerman.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 8696536

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN： 0954-6928            Impact factor:   1.439


× No keyword cloud information.
  4 in total

Review 1.  The future of endothelin-receptor antagonism as treatment for systemic hypertension.

Authors:  Gabriel Vorobiof; Burns C Blaxall; John D Bisognano
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

2.  Long-term endothelin receptor antagonism attenuates coronary plaque progression in patients with early atherosclerosis.

Authors:  Myeong Ho Yoon; Martin Reriani; Gössl Mario; Charanjit Rihal; Rajiv Gulati; Ryan Lennon; Jonella M Tilford; Lilach O Lerman; Amir Lerman
Journal:  Int J Cardiol       Date:  2013-01-03       Impact factor: 4.164

3.  Depot-medroxyprogesterone acetate and endothelial function before and after acute oral, vaginal, and transdermal estradiol treatment.

Authors:  Britta N Torgrimson; Jessica R Meendering; Paul F Kaplan; Christopher T Minson
Journal:  Hypertension       Date:  2011-02-28       Impact factor: 10.190

4.  Endothelial function, endothelin-1, and fibrinogen in young women using the vaginal contraceptive ring.

Authors:  Britta N Torgrimson; Jessica R Meendering; Nicole P Miller; Paul F Kaplan; Christopher T Minson
Journal:  Fertil Steril       Date:  2008-08-15       Impact factor: 7.329
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.